|
Volumn Suppl, Issue , 2007, Pages 9-14
|
Clinical management strategies for type 2 diabetes.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADAMANTANE;
ANTIDIABETIC AGENT;
DIPEPTIDYL PEPTIDASE IV;
DPP4 PROTEIN, HUMAN;
DRUG DERIVATIVE;
GLYCOSYLATED HEMOGLOBIN;
INCRETIN;
INSULIN;
METFORMIN;
NITRILE;
PYRROLIDINE DERIVATIVE;
UNCLASSIFIED DRUG;
VILDAGLIPTIN;
CLASSIFICATION;
DRUG ANTAGONISM;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
HUMAN;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET BETA CELL;
PATHOLOGY;
PATHOPHYSIOLOGY;
REVIEW;
ADAMANTANE;
ANTIGENS, CD26;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 2;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
INCRETINS;
INSULIN;
INSULIN-SECRETING CELLS;
METFORMIN;
NITRILES;
PYRROLIDINES;
MLCS;
MLOWN;
|
EID: 39049107622
PISSN: 15471896
EISSN: None
Source Type: Journal
DOI: 10.1097/01720610-200712000-00002 Document Type: Review |
Times cited : (2)
|
References (33)
|